August 18, 2025 · Form 4 insider transaction
Schwartz Jonathan David sold 1,680 shares of Rocket Pharmaceuticals Inc at $3.06 per share, a transaction worth $5.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.; The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.